Can analyses of electronic patient records be independently and externally validated? Study 2 - The effect of β-adrenoceptor blocker therapy on cancer survival: A retrospective cohort study

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Springate, David A ^a,b   Ashcroft, Darren M ^b   Kontopantelis, Evangelos ^a,b   Doran, Tim ^c   Ryan, Ronan ^d   Reeves, David ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BREAST CANCER; CANCER LOCALIZATION; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; ELECTRONIC MEDICAL RECORD; ESOPHAGUS CANCER; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS CANCER; PRESCRIPTION; PROSTATE CANCER; RETROSPECTIVE STUDY; ELECTRONIC HEALTH RECORD; EPIDEMIOLOGY; FACTUAL DATABASE; GREAT BRITAIN; NEOPLASMS; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; GREAT BRITAIN; HUMANS; NEOPLASMS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84929298029     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007299     Document Type: Article

References (40)

1. Reeves D, Springate DA, Ashcroft DM, et al. Can analyses of electronic patient records be independently and externally validated? The effect of statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case-control analysis. BMJ Open 2014;4:e004952.
2. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
3. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. BJGP 2010;60:e128-36.
4. Jordan K, Porcheret M, Croft P. Quality of morbidity coding in general practice computerized medical records: a systematic review. Fam Pract 2004;21:396-412.
5. Marston L, Carpenter JR, Walters KR, et al. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf 2010;19:618-26.
6. Delaney JA, Daskalopoulou SS, Brophy JM, et al. Lifestyle variables and the risk of myocardial infarction in the General Practice Research Database. BMC Cardiovasc Disord 2007;7:38.
7. Collins SC, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ 2010;340:c2442.
8. Madigan D, Ryan PB, Schuemie M, et al. Evaluating the Impact of Database Heterogeneity on Observational Study Results. Am J Epidemiol 2013;178:645-51.
9. Wijnans L, Lecomte C, de Vries C, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-54.
10. Dormuth CR, Hemmelgarn BR, Paterson JM, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ 2013;346:f880.
11. Filion KB, Chateau D, Targownik LE, et al. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut 2014;63:552-8.
12. Valkhoff VE, van Soest EM, Mazzaglia G, et al. Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study. Arthritis Rheum 2012;64:2792-802.
13. Andrews N, Stoweb J, Miller E, et al. A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark. Vaccine 2012;30:3042-6.
14. Bell C, Chakravarty A, Gruber S, et al. Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems. Pharmacoepidemiol Drug Saf 2014;23:1223-5.
15. Bremner SA, Carey IM, DeWilde S, et al. Early-life exposure to antibacterials and the subsequent development of hayfever in childhood in the UK: case-control studies using the General Practice Research Database and the Doctors' Independent Network. Clin Exp Allergy 2003;33:1518-25.
16. Bremner SA, Carey IM, DeWilde S, et al. Vaccinations, infections and antibacterials in the first grass pollen season of life and risk of later hayfever. Clin Exp Allergy 2007;37:512-7.
17. Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data. BMJ 2013;346:f114.
18. Clinical Practice Research Datalink (CPRD). http://www.cprd.com/home (accessed 20 Mar 2014).
19. QResearch. http://www.qresearch.org (accessed 20 Mar 2014).
20. Hippisley-Cox J, Coupland C. Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis. Heart 2006;92:752-8.
21. Carey IM, Cook DG, De Wilde S, et al. Developing a large electronic primary care database (Doctors' Independent Network) for Research. Int J Med Inform 2004;73:443-53.
22. Shah SM, Carey IM, Owen CG, et al. Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol 2011;72:157-61.
23. Carey IM, Cook DG, De Wilde S, et al. Implications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD). BMC Fam Pract 2003;4:14.
24. De Wilde S, Carey IM, Bremner SA, et al. Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart 2003;89:417-21.
25. De Wilde S, Carey IM, Bremner S. A comparison of the recording of 30 common childhood conditions in the Doctor's Independent Network and General Practice Research Databases. Health Stat Q 2004;22:21-31.
26. Chakroborty D, Sarkar C, Basu B, et al. Catecholamines regulate tumor angiogenesis. Cancer Res 2009;69:3727-30.
27. Cardwell CR, Coleman HG, Murray LJ, et al. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort. Int J Epidemiol 2013;42:1852-61.
28. Ganz PA, Habel LA, Weltzien EK, et al. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat 2011;129:549-56.
29. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 2011;29:2645-52.
30. Friedman GD, Udaltsova N, Habel LA. Norepinephrine antagonists and cancer risk. Int J Cancer 2011;128:737-8.
31. Jansen L, Below J, Chang-Claude J, et al. Beta blocker use and colorectal cancer risk: population-based case-control study. Cancer 2012;118:3911-19.
32. Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol 2012;4:113-25.
33. Springate DA, Kontopantelis E, Ashcroft DM, et al. ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records. PLoS ONE 2014;9:e99825.
34. http://data.gov.uk/dataset/imd-2004 (accessed 20 Oct 2014).
35. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
36. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2013. http://R-project.org (accessed 20 Nov 2014).
37. Speed TP. Iterative proportional fitting. Encyclopedia of Biostatistics 4. 2005. doi:10.1002/0470011815.b2a10027
38. Hicks BM, Murray LJ, Powe DG, et al. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort. Ann Oncol 2013;24:3100-6.
39. Cardwell CR, Coleman HG, Murray LJ, et al. Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK Clinical Practice Research Datalink cohort. Cancer Epidemiol 2014;38:279-85.
40. Kontopantelis E, Buchan I, Reeves D, et al. Relationship between quality of care and choice of clinical computing system: retrospective analysis of family practice performance under the UK's quality and outcomes framework. BMJ Open 2013;3:e003190.